SpyGlass Pharma, Inc. (SGP)

SpyGlass Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar 27, 2026	Dec 31, 2025	Dec 31, 2024
Market Capitalization	753	-	-
Enterprise Value	647	-	-
Debt / Equity Ratio	0.02	0.02	0.32
Net Debt / Equity Ratio	-1.00	-1.00	-1.02
Net Debt / EBITDA Ratio	2.59	2.59	-
Quick Ratio	12.57	12.57	2.14
Current Ratio	12.67	12.67	2.23
Return on Equity (ROE)	-67.70%	-67.70%	-
Return on Assets (ROA)	-37.23%	-37.23%	-
Return on Capital Employed (ROCE)	-38.60%	-38.60%	-174.30%
Buyback Yield / Dilution	-	-23.98%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q